XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2025
Sep. 29, 2024
Operating activities:    
Net income $ 142,837 $ 175,740
Loss from discontinued operations, net of income taxes 1,275 18,948
Income from continuing operations 144,112 194,688
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and other costs, net 24,368 22,119
Depreciation and amortization 302,261 322,816
Stock-based compensation 26,918 32,756
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) (59) 6,006
Amortization of deferred debt financing costs and accretion of discounts 3,560 5,051
Change in fair value of financial securities 3,484 (13,975)
Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business 222 (1,063)
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net (41,643) 33,291
Inventories 12,493 26,817
Accounts payable 270 (24,782)
Increase (Decrease) in Accrued Expenses and Other (68,990) (114,236)
Net cash provided by operating activities of continuing operations 406,996 489,488
Net cash used in operating activities of discontinued operations (6,023) (35,419)
Net cash provided by operating activities 400,973 454,069
Investing activities:    
Capital expenditures (53,351) (62,194)
Purchases of investments and notes receivables (29) (4,337)
Proceeds from investments and notes receivables 0 2,500
Proceeds from Sale and Maturity of Marketable Securities 0 710,000
Proceeds from Divestiture of Businesses 229 0
Net cash (used in) provided by investing activities of continuing operations (53,151) 645,969
Net cash provided by investing activities of discontinued operations 56,250 147,522
Net cash provided by investing activities 3,099 793,491
Financing activities:    
Repayments of Senior Debt 0 (711,479)
Payments of debt financing issuance costs (2,474) 0
Net payments on other credit facilities (158) (10,771)
Payment for Contingent Consideration Liability, Financing Activities (3,838) (8,832)
Proceeds from issuance of common stock under stock plans 2,632 6,173
Purchases of common stock (652,530) (184,421)
Dividends paid (24,845) (25,915)
Net cash used in financing activities (681,213) (935,245)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 45,264 4,120
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent (231,877) 316,435
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 1,164,452 914,373
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 932,575 1,230,808
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 931,386 1,229,778
Restricted Cash, Current 1,189 1,030
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 932,575 $ 1,230,808